Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

October 27, 2020

Protected PCI in COVID-19 Era: The Rise in Importance of Complete Revascularization

Cindy Grines, MD, FACC, MSCAI discusses best practices for using percutaneous mechanical circulatory support to enable complete revascularization in complex and sick patients, especially during the current COVID-19 era.

October 27, 2020

Achieving >70% AMICS Survival: Insights From National Cardiogenic Shock Initiative Study

William O'Neill, MD, shares insights from the National Cardiogenic Shock Initiative (NCSI) Study that are driving improved outcomes in patients with AMI cardiogenic shock. 

October 27, 2020

Results From PROTECT III, the Largest Prospective Multi-Center Single-Arm Study

Jeffrey Moses, MD, presents results from PROTECT III, the largest prospective study of Impella® for high-risk PCI in the real world.

October 27, 2020

Review RECOVER III and RECOVER IV Studies

William O’Neill, MD, reviews RECOVER III study data and introduces the RECOVER IV study.

October 22, 2020

Impella 5.5® with SmartAssist® Tip-to-Toe

Kevin Ray, global Impella® trainer, provides a tip-to-toe review of the Impella 5.5 with SmartAssist.

October 20, 2020

Rapid and Safe Adoption of the New Single Access Technique

Duane Pinto, MD, MPH, discusses the new single access technique, designed to avoid an additional arterial access, and reduce associated complications as well as make the procedure more rapid.

October 6, 2020

Your Destination for TCT 2020 Event Resources

TCT Connect highlighted the benefits of a more complete revascularization with Impella® heart pumps in high-risk PCI patients and the value of Impella protocol-based treatment for survival and native heart recovery in cardiogenic shock patients.

September 30, 2020

Impella® Experience in the UK: Clinical Utility, Indications, and Outcomes

Vasileios Panoulas, MD, and colleagues assess the clinical utility, indications, and outcomes of the Impella platform in their tertiary center in London, UK.

September 28, 2020

Impella 5.5® with SmartAssist®: Echocardiography for Real-time Positioning

Learn when and how to use echocardiography to visualize in real-time the relationship of the Impella 5.5 with SmartAssist to structures within the left ventricle.

September 25, 2020

Transferring to a Backup AIC

This quick skills video demonstrates the procedure for transferring Impella® support from one Automated Impella Controller (AIC) to another AIC.

September 22, 2020

Optimal Target MAP in Post-Cardiac Arrest AMI Shock

Ameloot et al. report significant reduction in myocardial injury with target MAP between 80/85 and 100 mmHg in post-cardiac arrest patients with shock after AMI.

September 16, 2020

Influence of Impella® Timing and Predicted Mortality Risk in Cardiogenic Shock

Prof. Andreas Schäfer, MD, discusses standardized use of Impella in AMICS and predicted mortality rates, timing of implantation, and patient selection based on predicted risk.

September 9, 2020

Better Than Anticipated Survival with Impella CP® and ECMO in Cardiogenic Shock

Steven P. Keller, MD, examines different mechanical circulatory support strategies for left ventricular unloading in ECMO supported patients in cardiogenic shock.

September 1, 2020

Treating Protected PCI & Impella® Therapies as Essential During COVID-19

Shami Mahmud, MD, FSCAI, discusses high-risk PCI (HRPCI) in the era of COVID-19.

August 30, 2020

Comparing Impella® to ECMO in AMICS

Lemor et al. demonstrate better clinical outcomes, fewer complications, shorter hospital stay, and lower cost with Impella compared to ECMO in AMICS.

NPS-1674